Stockreport

Recursion Pharmaceuticals (RXRX) Reports Q3 Loss, Misses Revenue Estimates [Yahoo! Finance]

Recursion Pharmaceuticals, Inc. - Class A  (RXRX) 
PDF This compares to loss of $0.43 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of -3.03 [Read more]